Authors: Cauwenberghs, N Ajzenberg, N Vauterin, S Hoylaerts, MF Declerck, PJ Baruch, D Deckmyn, H

Citation: N. Cauwenberghs et al., Characterization of murine anti-glycoprotein ib monoclonal antibodies thatdifferentiate between shear-induced and ristocetin/botrocetin-induced glycoprotein Ib-von Willebrand Factor interaction, HAEMOSTASIS, 30(3), 2000, pp. 139-148

Authors: Ajzenberg, N Ribba, AS Rastegar-Lari, G Meyer, D Baruch, D

Citation: N. Ajzenberg et al., Effect of recombinant von Willebrand factor reproducing type 2B or type 2Mmutations on shear-induced platelet aggregation, BLOOD, 95(12), 2000, pp. 3796-3803

Authors: Buffet, PA Gamain, B Scheidig, C Baruch, D Smith, JD Hernandez-Rivas, R Pouvelle, B Oishi, S Fujii, N Fusai, T Parzy, D Miller, LH Gysin, J Scherf, A

Citation: Pa. Buffet et al., Plasmodium falciparum domain mediating adhesion to chondroitin sulfate A: A receptor for human placental infection, P NAS US, 96(22), 1999, pp. 12743-12748

Authors: Perrault, C Ajzenberg, N Legendre, P Rastegar-Lari, G Meyer, D Lopez, JA Baruch, D

Citation: C. Perrault et al., Modulation by heparin of the interaction of the A1 domain of von Willebrand factor with glycoprotein Ib, BLOOD, 94(12), 1999, pp. 4186-4194

Authors: Vassilev, TL Kazatchkine, MD Van Huyen, JPD Mekrache, M Bonnin, E Mani, JC Lecroubier, C Korinth, D Baruch, D Schriever, F Kaveri, SV

Citation: Tl. Vassilev et al., Inhibition of cell adhesion by antibodies to Arg-Gly-Asp (RGD) in normal immunoglobulin for therapeutic use (intravenous immunoglobulin, IVIg), BLOOD, 93(11), 1999, pp. 3624-3631

Authors: Perrault, C Mekrache, M Schoevaert, D Kieffer, N Melchior, C Warszawski, J Baruch, D

Citation: C. Perrault et al., Ser 752 mutation to Pro or Ala in the beta 3 integrin subunit differentially affects the kinetics of cell spreading to von Willebrand factor and fibrinogen, CELL AD COM, 6(4), 1998, pp. 335-348